This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Patrick W. Kelley, MD, MPH; Robert R. Redfield, MD; David L. Ward, MD, MPH; Donald S. Burke, MD; Richard N. Miller, MD, MPH
Walter Reed Army Institute of Research Washington, DC

JAMA. 1986;256(16):2198-2199.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Although acquired immunodeficiency syndrome has been reported in prisons, the magnitude of human T-cell lymphotropic virus type III (HTLV-III) infection in inmates is not well defined.¹ The potential for intraprison transmission clearly exists if a reservoir of infection is present. A history of intravenous drug abuse has been documented by over 30% of inmates at several prisons.^2,3 Among a sample of federal penitentiary inmates, 30% admitted to adult homosexual activity in a prison.⁴ We undertook to document the prevalence and incidence of HTLV-III infection in a maximum-security military prison. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?